Liothyronine Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 6 USDMF, 3 CEP/COS, 1 JDMF, 2 EU WC, 1 KDMF, 7 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

52 FDF Dossiers, 28 FDA Orange Book, 7 Europe, 6 Canada, 3 Australia, 3 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.005MG BASE, TABLET;ORAL - EQ 0.025MG BASE, TABLET;ORAL - EQ 0.05MG BASE, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 18 SPI Pharma, 8 DKSH, 4 Gangwal Healthcare, 2 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 11 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 28 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 26 Direct Compression, 24 Thickeners and Stabilizers, 19 Taste Masking, 19 Lubricants & Glidants, 18 Chewable & Orodispersible Aids, 15 Granulation, 15 Controlled & Modified Release, 12 Co-Processed Excipients, 12 Disintegrants & Superdisintegrants, 10 Parenteral, 9 Empty Capsules, 8 Film Formers & Plasticizers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Solubilizers, 4 Rheology Modifiers, 2 Coloring Agents, 2 Topical

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 17 Regulatory FDF Prices

MARKET PLACE

17 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20105 / DOSAGE - INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LIOTHYRONINE SODIUM(UNII: GCA9VV7D2N) (LIOTHYRONINE - UNII:06LU7C9H1V)	LIOTHYRONINE	10ug in 1

Inactive Ingredients

Ingredient Name	Par Pharmaceutical, Inc.
ALCOHOL(3K9958V90M)
AMMONIA(5138Q19F1X)
ANHYDROUS CITRIC ACID(XF417D3PSL)

Setid 4cd4baf4 18d2 434f B80b 4f4b19996cf9 Applno 20105 Form Injectable Injection Dosage Eq 0 01mg Base Ml - Drug Product Composition: Liothyronine Sodium